From CDC Information Database
This database includes general CDC public health information on specific diseases and health related topics. When available, the database displays genomic information from various CDC web pages. Users are also encouraged to conduct searches of CDC website for additional information.
- CDC Newborn Screening Quality Assurance Program includes phenylketonuria
- CDC Information: Importance of Newborn Screening
From CDC-Authored Genomics Publication Database
This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.
- Phenylketonuria Scientific Review Conference: state of the science and future research needs.
Camp Kathryn M et al. Mol. Genet. Metab. 2014 Jun 112(2) 87-122 - Universal state newborn screening programs can reduce health disparities.
Brosco Jeffrey P et al. JAMA Pediatr 2015 Jan 169(1) 7-8 - Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States.
Hertzberg Vicki S et al. J. Pediatr. 2011 Oct 159(4) 555-60
From Implementation Database
This database focuses on state and national activities that integrate genomics into public health programs and clinical practice
- Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis
[Disease: NA; Type: Data; State: Multiple States] - Kentucky Newborn Screening Program
[Disease: NA; Type: Program; State: Kentucky] - Newborn Screening in Nebraska
[Disease: NA; Type: Program; State: Nebraska] - Newborn Screening
[Disease: NA; Type: Program; State: Nevada] - Newborn Screening Program
[Disease: NA; Type: Program; State: New Hampshire]
From Guideline Database
This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.
No hay comentarios:
Publicar un comentario